Universita Di Bologna

Laboratori Balducci S.p.a.

Giuseppina Di Stefano

Luigi Fiume

Massimo Baldacci

Alessandro Mattioli

Corrado Busi

Marcella Lanza

A procedure is described for conjugating the hydrazone derivatives of doxorubicin having a maleimide terminal group to lactosaminated human albumin (L-HSA). The procedure is based on the use of trialkyiphosphines to reduce the disulfide bonds of the protein and make its SH groups available for the formation of the thioether bond. In comparison with the conjugation obtained by using thiol reducing agents, such as dithiothreitol, this has the advantage that even when it is performed under very simple conditions, specifically without using an inert atmosphere, in the absence of oxygen, and without preliminary purification of the 'reduced' L-HSA, it does not bring about the formation of a precipitate in the reaction means. In comparison with conjugation to L-HSA thiolated by using iminothiolane, the novel procedure has the advantage of greater simplicity and of not introducing exogenous molecules into the L-HSA in order to make the SH groups available.

Process for the preparation of doxorubicin conjugates with lactosaminated human albumin

The present invention refers to conjugated compounds of antiviral drugs having hepatotropic activity, methods of making these compounds, and compositions thereof.

Hepatotropic conjugates of antiviral drugs carriers thereof and

Growing community of inventors

Bologna, Italy

Giuseppina Di Stefano